Skip to main content
CONTEC MEDICAL SYSTEMS CO., LTD. logo

CONTEC MEDICAL SYSTEMS CO., LTD. — Investor Relations & Filings

Ticker · 300869 ISIN · CNE1000047F0 LEI · 6556007SL3V6YKCWVA55 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 789 across all filing types
Latest filing 2022-10-26 Interim / Quarterly Rep…
Country CN China
Listing Shenzhen Stock Exchange 300869

About CONTEC MEDICAL SYSTEMS CO., LTD.

https://www.contecmed.com.cn

CONTEC Medical Systems Co., Ltd. focuses on the research, development, manufacturing, and distribution of medical electronic instruments. The product portfolio encompasses a wide range of diagnostic and monitoring solutions, including pulse oximeters, blood pressure monitors, electrocardiographs, ultrasound equipment, and multi-parameter patient monitors. Additionally, the company provides specialized devices such as fetal monitors, sleep apnea screening systems, and biochemical analyzers. By leveraging integrated research and large-scale production facilities, the organization delivers medical technology designed for clinical, hospital, and home healthcare environments. The company emphasizes technical innovation and adheres to international quality standards to ensure the precision and reliability of its medical hardware and software solutions.

Recent filings

Filing Released Lang Actions
2022年三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2022 Third Quarter Report" of 康泰医学系统（秦皇岛）股份有限公司, which clearly indicates it is a quarterly financial report. It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and explanations of financial changes for the third quarter of 2022. The document explicitly states it is unaudited and covers the period ending September 30, 2022. The length of the document (over 12,000 characters) and the presence of substantive financial data confirm it is a full interim/quarterly report rather than a brief announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q3 2022
2022-10-26 Chinese
关于医疗器械注册证变更的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from 康泰医学系统（秦皇岛）股份有限公司 regarding changes to medical device registration certificates issued by the Hebei Provincial Drug Administration. It details specific product registration certificate changes, including new models and scope adjustments. The document includes a risk warning and impact statement on the company's business. It is a regulatory announcement about product registration changes, not a financial report, earnings release, or management discussion. The document length is short (1053 characters) and it is an announcement of regulatory changes rather than a report or detailed financial filing. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2022-10-26 Chinese
关于公司产品通过美国FDA审核的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the approval of a company product by the U.S. FDA. It contains no financial data, no report or presentation, and no regulatory filing related to financial performance or corporate governance. It is an official company announcement about product approval, which does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings related to financial or governance matters. Given the content and length, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous company announcements that do not fit other specific categories.
2022-10-19 Chinese
联合资信评估股份有限公司关于康泰医学系统(秦皇岛)股份有限公司收到深交所监管函的关注公告
Regulatory Filings Classification · 95% confidence The document is a regulatory announcement from a credit rating agency regarding a regulatory letter issued by the Shenzhen Stock Exchange to the company. It discusses compliance issues and the impact on credit ratings but does not contain financial statements or detailed financial data. The document is short (819 characters) and serves as a public notice about regulatory concerns and credit rating updates. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement and does not fit other specific categories.
2022-10-14 Chinese
第三届董事会第二十三次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of a board meeting resolution by 康泰医学系统（秦皇岛）股份有限公司. It details the convening of the third board's 23rd meeting, the agenda discussed, and the voting results regarding the decision not to adjust the convertible bond's conversion price downward. The document includes procedural details about the meeting and voting but does not contain financial statements or detailed financial analysis. It is a formal disclosure of board decisions, specifically about bond conversion price adjustments, and mentions the board chairman's abstention from voting due to personal holdings. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the company's board or senior management. The document length is short and focused on board resolutions, not a full report or financial release.
2022-10-10 Chinese
关于不向下修正康医转债转股价格的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from 康泰医学系统（秦皇岛）股份有限公司 regarding the decision not to downward adjust the conversion price of its convertible bonds (康医转债). It includes details about the bond issuance, listing, conversion period, and the specific board resolution on the matter. The document is a formal disclosure about a capital market event related to convertible bonds and their terms, specifically about the decision on conversion price adjustment. It is not a full financial report, earnings release, or management discussion. It is also not a proxy statement or voting result announcement, but rather a capital/financing update related to convertible bond terms and board decisions on those terms. The document length is under 5,000 characters and contains substantive content about financing terms and board decisions, fitting the Capital/Financing Update category.
2022-10-10 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.